대한신장학회

논문분류	춘계학술대회 초록집
제목	AST-120 Ameliorates Cognitive and Emotional Dysfunction in a 5/6 Nephrectomy Chronic Kidney Disease Model
저자	DONG JIN LEE
출판정보	2024; 2024(1):
키워드
초록	Objectives: Chronic Kidney Disease (CKD) is intricately associated with cognitive impairment, a connection often attributed to elevated levels of uremic toxins, particularly Indoxyl sulfate. While existing evidence emphasizes the detrimental effects of Indoxyl sulfate on cognitive function in CKD, there is a notable dearth of research investigating the potential cognitive improvements resulting from its reduction. This study aims to address this gap by examining the impact of AST-120, a therapeutic agent known to reduce Indoxyl sulfate levels, on cognitive and emotional functions in a 5/6 nephrectomy CKD model. Methods: Male Sprague Dawley rats underwent 5/6 nephrectomy, and AST-120 was administered over a 10-week period. Behavioral assessments, including novel object recognition, Y-maze, Barnes maze, and classical contextual fear conditioning, were employed to evaluate cognitive and emotional functions. Immunohistochemical staining, including double immunofluorescent staining for aquaporin-4 and glial fibrillary acidic protein, provided insights into hippocampal alterations. Additionally, electrophysiological recordings of hippocampal field excitatory postsynaptic potential (fEPSP) were conducted. Results: The CKD model exhibited significant deficits in spatial working memory, learning, memory, and object recognition. Immunohistochemical analyses revealed coexpression of aquaporin-4 and glial fibrillary acidic protein, supporting hippocampal blood-brain barrier changes. AST-120 administration led to a notable reduction in Indoxyl sulfate levels and correlated with improved cognitive and emotional functions, as evidenced by enhanced performance in behavioral assays and normalized fEPSP in the hippocampus. Conclusions: This study establishes a critical link between elevated Indoxyl sulfate levels in CKD and cognitive dysfunction, emphasizing the potential therapeutic impact of AST-120 in ameliorating cognitive and emotional deficits. By reducing Indoxyl sulfate, AST-120 emerges as a promising intervention to enhance cognitive function in CKD, suggesting avenues for future therapeutic strategies targeting uremic toxins in neurocognitive disorders associated with renal dysfunction.
원문(PDF)	PDF 원문보기

간행물 검색

대한신장학회 회원관리 규정